Share

Positive Top-Line Results Announced from the Pivotal Phase 3 SONICS Study of Levoketoconazole for the Treatment of Endogenous Cushing’s Syndrome

Positive top-line results this week were announced from the multinational, pivotal Phase 3 SONICS study evaluating levoketoconazole for the treatment of endogenous Cushing’s syndrome. Strongbridge Biopharma is marketing the drug as RECORLEV™ . The open-label, single-arm SONICS study achieved statistical significance of its pre-specified primary endpoint, with 30 percent of patients achieving normalization of mean urinary...
Share

Listen to Episode 4 of the Endocrine News Podcast

Episode 4 of the Endocrine News Podcast has arrived, in which Angela Magdaleno, DO, of the Lehigh Valley Health Network, discusses preconception counseling for women with diabetes. Listen here: https://www.endocrine.org/podcast#enp4 And check out the links below for further reading: https://www.endocrine.org/meetings/endo-annual-meetings/abstract-details?id=6796 — ENDO 2018 abstract: Preconception Counseling: Frequently Forgotten by Primary Care Providers due to Multiple Barriers...
Share

FDA Approves First Treatment for Rare Adrenal Tumors

The U.S. Food and Drug Administration this week approved iobenguane I 131 injection for intravenous use for the treatment of adults and adolescents age 12 and older with rare tumors of the adrenal gland (pheochromocytoma or paraganglioma) that cannot be surgically removed (unresectable), have spread beyond the original tumor site, and require systemic anticancer therapy....
Share

Congratulating the 2018 Endocrine Fellows Series Awardees 

Congratulations to the 2018 awardees for this year’s Osteoporosis Fellows Series being held August 1 — 2 in Santa Fe, New Mexico. This two-day conference is designed for clinical endocrine fellows in adult and pediatric programs that are looking to update their knowledge of rare bone diseases and clinical best practices.  The faculty will select the top four abstracts presented at the Osteoporosis conference for an additional speaking session at the Santa Fe Bone...

As much as we know today about the endocrine system and the effects it has on the body, there remains so much that we do not know. Discoveries are made every day, and our understanding of the endocrine system is always growing and changing. Serving patients to the best of an endocrinologist’s abilities means being aware of all the latest developments in endocrine research. This includes the newest and most complete information concerning such endocrinology research topics as new treatments and new methods for disease prevention. Identifying symptoms and making the connections between those symptoms and endocrine disease can lead to greater understanding and ultimately better treatment for patients. More advanced prevention techniques can help patients stave off disease before it can impact their lives. Having the most current information can make a tremendous difference in the quality of life for your patients.

This section features some of the most current and forward-looking articles concerning the latest research in endocrinology. Written by and for endocrinologists, these articles are provided to keep you up to date with the most relevant developments in the field of endocrinology. You can access the information you need about new technology, new treatments and general information to help you serve your patients with better overall care. Our understanding of the endocrine system is always evolving. With Endocrine News, you can ensure that your knowledge of the field won’t be left behind. What’s more, your patients will always have access to the most advanced information out there.